Type 1 Diabetes Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with Type 1 Diabetes.
- People who have had diabetes for more than 12 months at the time of screening.
- Adults aged 18 years or older.
- People whose HbA1c (a blood sugar level measured over roughly 3 months) is above 57 mmol/mol at screening.
- People who have been using a continuous glucose monitor (a small device that tracks blood sugar levels throughout the day) for more than three months before screening and who are able to continue using one during the study.
- People who have been using both a long-acting (basal) and short-acting (bolus) insulin for more than three months before screening and who are able to continue this during the study.
- People who are able and willing to provide written consent to participate.
Who may not be able to join:
- Women who are currently pregnant or who plan to become pregnant during the study period.
- People with cognitive difficulties or other conditions that the study doctor determines are not compatible with taking part.
- People who have a planned change to their diabetes medication during the study period (note: switching between mealtime insulins that work in the same way may be allowed — confirm with trial site).
- People who plan to change the type of continuous glucose monitor they use during the study.
- People with food allergies or intolerances that would make it difficult to follow Nordic nutrition guidelines.
- People who are currently using, or plan to use, corticosteroid medications during the study (except when used as replacement therapy for a medical condition).
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Elisabeth Stoltz Sjöström, Associate professor, Department of Food, Nutrition and Culinary Science, Umeå University, Sweden
Phone: +46171418551
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Time in range - Percentage of time spent with blood glucose levels between 3.9-10 mmol/l.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.